Artificial intelligence is emerging as a powerful tool for improving the diagnosis, phenotyping, and treatment of inflammatory skin diseases such as alopecia.

Minimal disease activity in atopic dermatitis is sustainable at one year in early responders. Discover predictors and ...

Patients with major depressive disorder and patients with inflammatory skin diseases like atopic dermatitis share similar immune abnormalities, notably in the Th2 pathway, according to a study ...

Panelists discuss how atopic dermatitis involves complex inflammatory and neuronal pathways, with IL-4, IL-13, and IL-31 cytokines driving Th2-mediated inflammation that varies across different racial ...

As a wealth of data accumulated in recent decades has confirmed, some dermatologic diseases are associated with clinical depression and clinical anxiety, which are in turn often linked to substance ...

Emerging evidence supports the skin microbiome as a promising avenue for precision medicine in the treatment of dermatologic diseases.

Recent evidence indicates that a significant percentage of patients with recalcitrant eczematous dermatitis, including those dubbed "treatment-resistant" to dupilumab (Dupixent), may be living with a ...

Max Homa shares his journey with seborrheic dermatitis to encourage others to take control of their symptomsZORYVE® (roflumilast) foam 0.3% is a ...

If your current atopic dermatitis treatment isn’t working, it’s time for a change. Learn how the latest oral therapies can help you thrive.